Bluesky Facebook Reddit Email

Cocaine use linked to poor adherence to antiretroviral therapy in HIV patients

06.27.02 | NIH/National Institute on Drug Abuse

Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

The study's lead investigator, Dr. Julia H. Arnsten, says that active cocaine use was the strongest predictor of poor adherence and, in turn, failure to maintain viral suppression. Overall adherence among cocaine users was 27 percent, compared with 68 percent among subjects who reported no cocaine use during the 6-month study period. Thirteen percent of active cocaine users maintained viral suppression, compared with 46 percent of nonusers.

The study was funded by the National Institute on Drug Abuse, a component of the National Institutes of Health.

WHAT IT MEANS: The findings from this study indicate that interventions to improve adherence to drug regimens to treat HIV infection should include assessing and treating cocaine use by patients.

This study was published in the May 2002 issue of the Journal of General Internal Medicine, which was a special issue devoted to the subject of substance abuse.

Journal of General Internal Medicine

Keywords

Article Information

Contact Information

Michelle Person
NIH/National Institute on Drug Abuse
mperson@mail.nih.gov

How to Cite This Article

APA:
NIH/National Institute on Drug Abuse. (2002, June 27). Cocaine use linked to poor adherence to antiretroviral therapy in HIV patients. Brightsurf News. https://www.brightsurf.com/news/19V9DG08/cocaine-use-linked-to-poor-adherence-to-antiretroviral-therapy-in-hiv-patients.html
MLA:
"Cocaine use linked to poor adherence to antiretroviral therapy in HIV patients." Brightsurf News, Jun. 27 2002, https://www.brightsurf.com/news/19V9DG08/cocaine-use-linked-to-poor-adherence-to-antiretroviral-therapy-in-hiv-patients.html.